logo
Search orAI Icon𝛼SK
ENTITY

Shield Therapeutics (STX LN)

40
Analysis
Health Care • United Kingdom
Shield Therapeutics plc, a specialty pharmaceutical company, focuses on the development and commercialization of secondary care-focused pharmaceuticals. Its lead product is Feraccru, a novel therapy for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease. Its products pipeline includes PT20, a novel iron-based phosphate binder for the treatment of hyperphosphatemia related to chronic kidney disease (CKD); PT30 and PT40 that are intravenous iron formulations; and Feraccru to treat patients with IDA related to CKD and other indications. The company was founded in 2008 and is based in Gateshead Quays, the United Kingdom.
more
Company Event • 23 Apr 2026 14:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 23 Oct 2025 22:00 • Latest

Trading Update

Company Event • 03 Sep 2025 14:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 23 Jul 2025 22:00

Trading Update

Company Event • 24 Apr 2025 14:00 • Upcoming
Add To Calendar

H2 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x